Consumer Products
Medical
Therapy

Marker Therapeutics

$5.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (0.69%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!

About

Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Read More The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Employees
11
Headquarters
Houston, Texas
Founded
1991
Market Cap
265.63M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
368.69K
High Today
$5.96
Low Today
$5.76
Open Price
$5.80
Volume
121.53K
52 Week High
$13.55
52 Week Low
$3.90

Collections

Consumer Products
Medical
Therapy
Retail
Health
US
North America

News

Yahoo FinanceMay 7

Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference

HOUSTON, May 7, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its President and Chief Executive Officer, Peter L. Hoang, will be presenting at the 2019 Bank of America Merrill Lynch Health Care Conference on Thursday, May 16, 2019. Marker Therapeutics, Inc. (PRNewsfoto/Marker Therap...

50

Earnings

Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.